← FDA DRUG APPROVALS

FDA ANDA · ANDA077947

FLUCONAZOLE IN SODIUM CHLORIDE 0.9%

Sponsor: BAXTER HLTHCARE CORP

APPLICATION
ANDA077947
TYPE
ANDA
ORIGINAL APPROVAL
2010-05-26
LATEST ACTION
2014-11-10
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

FLUCONAZOLE IN SODIUM CHLORIDE 0.9%Discontinued
FLUCONAZOLE 200MG/100ML (2MG/ML) · INJECTABLE · INJECTION
FLUCONAZOLE IN SODIUM CHLORIDE 0.9%Discontinued
FLUCONAZOLE 400MG/200ML (2MG/ML) · INJECTABLE · INJECTION

Approval history

2014-11-10Labeling · Supplement 2 · standardAP
2014-11-10Labeling · Supplement 3 · standardAP
2010-05-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →